Hence, to determine the molecular basis of high FXR1 protein levels in cancer cells, we used A549 lung cancer cells, which show metastatic phenotype under the treatment of cytokine transforming growth factor-β (TGFβ) (56). This evidence concerns the gene FXR1 and cancer.